Zefeng Shen

810 total citations
26 papers, 558 citations indexed

About

Zefeng Shen is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zefeng Shen has authored 26 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zefeng Shen's work include Bladder and Urothelial Cancer Treatments (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Urinary and Genital Oncology Studies (4 papers). Zefeng Shen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Urinary and Genital Oncology Studies (4 papers). Zefeng Shen collaborates with scholars based in China, United States and Australia. Zefeng Shen's co-authors include Haiyang Wu, Jianqiu Kong, Qiang Guo, Weiguang Yang, Kunming Cheng, Tianxin Lin, Jintao Hu, Zeshi Chen, Zaijie Sun and Lihu Gu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Zefeng Shen

24 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zefeng Shen China 13 158 158 126 75 68 26 558
Xiaohui Hao China 13 173 1.1× 70 0.4× 144 1.1× 47 0.6× 58 0.9× 45 590
Peide Huang China 10 250 1.6× 153 1.0× 61 0.5× 40 0.5× 112 1.6× 15 884
Wenqing Hu China 14 146 0.9× 140 0.9× 87 0.7× 83 1.1× 66 1.0× 62 452
Gervith Reyes-Soto Mexico 8 69 0.4× 102 0.6× 114 0.9× 56 0.7× 34 0.5× 32 371
Shitao Jiang China 11 92 0.6× 86 0.5× 68 0.5× 51 0.7× 65 1.0× 31 384
Chong Liu China 14 167 1.1× 79 0.5× 62 0.5× 121 1.6× 102 1.5× 71 541
Yan Jin China 16 202 1.3× 76 0.5× 65 0.5× 87 1.2× 58 0.9× 78 722
Fulya Çakalağaoğlu Türkiye 15 177 1.1× 101 0.6× 106 0.8× 137 1.8× 64 0.9× 61 590

Countries citing papers authored by Zefeng Shen

Since Specialization
Citations

This map shows the geographic impact of Zefeng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zefeng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zefeng Shen more than expected).

Fields of papers citing papers by Zefeng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zefeng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zefeng Shen. The network helps show where Zefeng Shen may publish in the future.

Co-authorship network of co-authors of Zefeng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Zefeng Shen. A scholar is included among the top collaborators of Zefeng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zefeng Shen. Zefeng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yi‐Hsiang, et al.. (2024). A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues. Frontiers in Immunology. 15. 1297542–1297542. 3 indexed citations
3.
Kong, Jianqiu, Hua Zhou, Ying Lin, et al.. (2024). Assessing the predictive value of smoking history for immunotherapy outcomes in bladder cancer patients. Frontiers in Immunology. 15. 1404812–1404812. 2 indexed citations
4.
Cheng, Kunming, Zefeng Shen, Yanqiu Lu, et al.. (2023). Mapping knowledge landscapes and emerging trends of sonodynamic therapy: A bibliometric and visualized study. Frontiers in Pharmacology. 13. 1048211–1048211. 31 indexed citations
5.
Chen, Tianyi, Zhiyu Jiang, Jia-Fei Yan, et al.. (2023). Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma. International Journal of Biological Sciences. 19(7). 2114–2131. 38 indexed citations
6.
Li, Zitong, et al.. (2023). Inflammatory bowel disease is causally related to irritable bowel syndrome: a bidirectional two-sample Mendelian randomization study. Frontiers in Medicine. 10. 1166683–1166683. 3 indexed citations
7.
Kong, Jianqiu, Sihong Lu, Long Zhang, et al.. (2022). m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent. Frontiers in Immunology. 13. 1014861–1014861. 12 indexed citations
8.
Shen, Zefeng, Haiyang Wu, Zeshi Chen, et al.. (2022). The Global Research of Artificial Intelligence on Prostate Cancer: A 22-Year Bibliometric Analysis. Frontiers in Oncology. 12. 843735–843735. 81 indexed citations
9.
Shen, Zefeng, Jintao Hu, Haiyang Wu, et al.. (2022). Global research trends and foci of artificial intelligence-based tumor pathology: a scientometric study. Journal of Translational Medicine. 20(1). 409–409. 48 indexed citations
10.
Cheng, Kunming, Qiang Guo, Zefeng Shen, et al.. (2022). Bibliometric Analysis of Global Research on Cancer Photodynamic Therapy: Focus on Nano-Related Research. Frontiers in Pharmacology. 13. 927219–927219. 77 indexed citations
11.
Shen, Zefeng, et al.. (2022). The global research of bladder cancer immunotherapy from 2012 to 2021: A bibliometric analysis. Frontiers in Oncology. 12. 999203–999203. 6 indexed citations
12.
Liu, Kun, et al.. (2022). Knowledge mapping and research hotspots of immunotherapy in renal cell carcinoma: A text-mining study from 2002 to 2021. Frontiers in Immunology. 13. 969217–969217. 26 indexed citations
13.
Cheng, Kunming, Qiang Guo, Zefeng Shen, et al.. (2022). Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field. Frontiers in Oncology. 12. 948389–948389. 28 indexed citations
14.
Hu, Jintao, Zefeng Shen, Hao Yu, et al.. (2022). A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs. Frontiers in Oncology. 12. 833763–833763. 7 indexed citations
15.
Li, Zitong, et al.. (2022). Global trends in gut microbiota and clostridioides difficile infection research: A visualized study. Journal of Infection and Public Health. 15(7). 806–815. 7 indexed citations
16.
Mo, Jiahang, Xiao Hu, Lihu Gu, et al.. (2020). Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis. World Journal of Surgical Oncology. 18(1). 15–15. 57 indexed citations
17.
18.
Shen, Zefeng, et al.. (2019). Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 17(1). 4–4. 49 indexed citations
19.
Wang, Guangzhi, Xigan He, Lichao Xu, et al.. (2019). Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours. Current Oncology. 26(5). 658–664. 7 indexed citations
20.
Cheng, Yanzhen, Zefeng Shen, Jiaxin Peng, et al.. (2016). ACE inhibitors and the risk of fractures: a meta-analysis of observational studies. Endocrine. 55(3). 732–740. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026